The Role of Micro RNAs in Regulating PI۳K/AKT Signaling Pathways in Glioblastoma

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 161

فایل این مقاله در 15 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJP-17-2_002

تاریخ نمایه سازی: 18 فروردین 1401

چکیده مقاله:

Glioblastoma is a type of brain cancer with aggressive and invasive nature. Such features result from increased proliferation and migration and also poor apoptosis of glioma cells leading to resistance to current treatments such as chemotherapy and radiotherapy. In recent studies, micro RNAs have been introduced as a novel target for treating glioblastoma via regulation of apoptotic signaling pathway, remarkably PI۳K/AKT, which affect cellular functions and blockage or progression of the tumor. In this review, we focus on PI۳K/AKT signaling pathway and other related apoptotic processes contributing to glioblastoma and investigate the role of micro RNAs interfering in apoptosis, invasion and proliferation of glioma through such apoptotic processes pathways. Databases NCBI, PubMed, and Web of Science were searched for published English articles using keywords such as 'miRNA OR microRNA', 'Glioblastoma', 'apoptotic pathways', 'PI۳K and AKT', 'Caspase signaling Pathway' and 'Notch pathway'. Most articles were published from ۷ May ۲۰۱۵ to ۱۶ June ۲۰۲۰. This study focused on PI۳K/AKT signaling pathway affecting glioma cells in separated subparts. Also, other related apoptotic pathways as the Caspase cycle and Notch have been also investigated. Nearly ۴۰ miRNAs were found as tumor suppressors or onco-miRNA, and their targets, which regulated subcomponents participating in proliferation, invasion, and apoptosis of the tumoral cells. Our review reveals that miRNAs affect key molecules in signaling apoptotic pathways, partly PI۳K/AKT, making them potential therapeutic targets to overcome the tumor. However, their utility as a novel treatment for glioblastoma requires further examination and investigation.

کلیدواژه ها:

نویسندگان

Roshanak Ghaffarian Zirak

Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Hurie Tajik

Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Science, Shahrekord, Iran

Jahanbakhsh Asadi

Department of Clinical Biochemistry, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran

Pedram Hashemian

Jahad Daneshgahi Research Committee, Jahad Daneshgahi Institute, Mashhad, Iran

Hossein Javid

Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Kleihues P, Sobin LH. World Health Organization classification of tumors. ...
  • Zhang CZ, Zhang JX, Zhang AL, Shi ZD, Han L, ...
  • Chu SH, Feng DF, Zhang H, Chen ET, Duan ZX, ...
  • Shinbo Y, Taira T, Niki T, Iguchi-Ariga SM, Ariga H. ...
  • Guo P, Yu Y, Li H, Zhang D, Gong A, ...
  • Zhang C, Wang G, Kang C, Du Y, Pu P. ...
  • Gillies JK, Lorimer IA. Regulation of p۲۷Kip۱ by miRNA ۲۲۱/۲۲۲ ...
  • Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-۲۱ targets a network ...
  • Fulda S. Cell death-based treatment of glioblastoma. Cell Death Dis. ...
  • نمایش کامل مراجع